📰 Nasdaq Imcc News
Page 2 - Nasdaq Imcc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Imcc. Real-time updates on events, politics, business and more.
May 1, 2023
IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 42,500 shares, a growth of 7.3% from the March 31st total of 39,600 shares. Based on an average daily trading volume, of 112,500 shares, the short-interest ratio is presently 0.4 […]
April 18, 2023
IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 39,600 shares, a growth of 85.9% from the March 15th total of 21,300 shares. Approximately 0.7% of the company’s stock are short sold. Based on an average […]
April 16, 2023
IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 39,600 shares, an increase of 85.9% from the March 15th total of 21,300 shares. Based on an average daily volume of 114,900 shares, the days-to-cover ratio is […]
April 3, 2023
Alliance Global Partners cut shares of IM Cannabis (NASDAQ:IMCC – Get Rating) from a buy rating to a neutral rating in a research note published on Thursday, The Fly reports. IM Cannabis Stock Down 3.2 % Shares of NASDAQ IMCC opened at $0.72 on Thursday. The company has a debt-to-equity ratio of 0.02, a current […]
March 28, 2023
IM Cannabis (NASDAQ:IMCC – Get Rating) and Curaleaf (OTCMKTS:CURLF – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Valuation & Earnings This table compares IM Cannabis and Curaleaf’s […]
June 20, 2022
IM Cannabis (NASDAQ:IMCC – Get Rating) and ChromaDex (NASDAQ:CDXC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, valuation, profitability, analyst recommendations, earnings and dividends. Earnings and Valuation This table compares IM Cannabis and ChromaDex’s […]
June 12, 2022
IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 232,500 shares, an increase of 120.8% from the May 15th total of 105,300 shares. Based on an average daily trading volume, of 256,100 shares, […]
May 20, 2022
Zacks Investment Research lowered shares of IM Cannabis (NASDAQ:IMCC – Get Rating) from a hold rating to a sell rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, “IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and […]
May 6, 2022
IM Cannabis (NASDAQ:IMCC – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, May 12th. Analysts expect IM Cannabis to post earnings of ($0.01) per share for the quarter. IM Cannabis has set its Q4 2021 guidance at EPS and its FY 2021 guidance at EPS. IM Cannabis (NASDAQ:IMCC […]
April 16, 2022
IM Cannabis Corp. (NASDAQ:IMCC – Get Rating) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 357,500 shares, a growth of 138.0% from the March 15th total of 150,200 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average daily […]